Why the study?
Does known or new-onset atrial fibrillation impact the 2-year cardiovascular event rate in patients with acute coronary syndromes?
Does known or new-onset atrial fibrillation impact the 2-year cardiovascular event rate in patients with acute coronary syndromes?
Answers are grounded in this paper and cite their sources.
In patients with acute coronary syndromes, prior atrial fibrillation is an independent predictor of 2-year mortality and ischemic events, yet anticoagulant use remains suboptimal.
Acute coronary syndrome patients with AF represent a high-risk group with increased event rates during long-term follow-up. Prior AF is an independent predictor of mortality and/or ischaemic events at 2 years. Use of anticoagulants in AF after acute coronary syndrome is still suboptimal.
No takes yet. Share an insight, caveat, or question.
Zeymer et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: